Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0030 (-4.92%)
Aug 11, 2026, 3:53 PM AEST
Genetic Signatures Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 19.94 | 19.75 | 13.77 | 21.51 | 35.5 | 28.38 |
Revenue Growth | 0.92% | 43.47% | -36.00% | -39.39% | 25.06% | 105.43% |
Gross Profit Gross Profit Growth | 10.12 | 10.51 | 5.86 | 9.68 | 21.9 | 17.14 |
Operating Income Operating Income Growth | -12.21 | -14.63 | -18.33 | -14.59 | 3.03 | 1.53 |
Net Income Net Income Growth | -11.27 | -20.1 | -17.86 | -14.05 | 3.06 | 1.76 |
Earnings Per Share EPS Growth | -0.05 | -0.09 | -0.11 | -0.10 | 0.02 | 0.01 |
EPS Growth | - | - | - | - | 74.39% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EMEA EMEA Growth | 3.14 | 2.91 | 1.11 | 1.62 | 4.19 | 4.45 |
Eliminations Eliminations Growth | -2.7 | -2.55 | -0.38 | -1.31 | -3.71 | -3.24 |
Asia Pacific Asia Pacific Growth | 15.15 | 15.23 | 9.01 | 16.23 | 34.8 | 25.4 |
Americas Americas Growth | - | 0.3 | 0.03 | 0.39 | 0.14 | 1.68 |
Unallocated Unallocated Growth | 5.49 | 3.85 | 4 | 4.57 | - | - |
Total Total Growth | 21.57 | 19.75 | 13.77 | 21.51 | 35.42 | 28.28 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 29.87 | 31.3 | 36.25 | 16.35 | 36.9 | 30.12 |
Total Debt Total Debt Growth | 0.56 | 0.79 | 1.22 | - | 0.03 | 0.4 |
Net Cash (Debt) Net Cash Growth | 29.31 | 30.5 | 35.03 | 16.35 | 36.86 | 29.72 |
Net Cash Growth | -3.91% | -12.92% | 114.27% | -55.65% | 24.03% | -2.34% |
Net Cash Per Share Net Cash Per Share Growth | 0.13 | 0.13 | 0.21 | 0.11 | 0.25 | 0.20 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -9.6 | -12.29 | -10.12 | -12.45 | 9.81 | 4.2 |
Capital Expenditures CapEx Growth | -1.07 | -0.65 | -1.98 | -1.93 | -1.71 | -4.65 |
Free Cash Flow Free Cash Flow Growth | -10.67 | -12.94 | -12.1 | -14.38 | 8.09 | -0.46 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 50.78% | 53.19% | 42.53% | 45.01% | 61.69% | 60.38% |
Operating Margin | -61.22% | -74.06% | -133.14% | -67.83% | 8.54% | 5.38% |
Pretax Margin | -56.53% | -101.78% | -129.74% | -65.32% | 8.63% | 6.19% |
Profit Margin | -56.53% | -101.78% | -129.74% | -65.32% | 8.63% | 6.19% |
FCF Margin | -53.52% | -65.52% | -87.88% | -66.86% | 22.80% | -1.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | - | - | 54.30 | 89.52 |
Forward PE | - | 85.15 | 85.15 | 85.15 | 85.15 | 85.15 |
P/FCF Ratio | - | - | - | - | 20.56 | - |
PS Ratio | 0.66 | 4.20 | 11.26 | 3.50 | 4.69 | 5.54 |